No Data
US Stock MarketDetailed Quotes
SSMXY SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS
Watchlist
27.090
-0.440-1.60% Trading 12/05 09:54 ET
27.750High27.080Low16.61KVolume
27.750Open27.530Pre Close457.71KTurnover0.00%Turnover Ratio38.53P/E (TTM)11.34BMarket Cap36.57052wk High32.92P/E (Static)418.61MShares22.18052wk Low3.98P/B11.34BFloat Cap69.410Historical High0.13Dividend TTM418.61MShs Float22.180Historical Low0.48%Div YieldTTM2.43%Amplitude27.562Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS Company
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Revenue Breakdown
Business
Currency:JPY
2023/03/31
Stock NameRevenueRatio
Single segment410.5B100.00%
News
Fujirebio and Sysmex Expand CDMO Partnership Into the Field of Neurodegenerative Diseases Under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development and
Urine Cell Analyzer Market Analysis 2023-2028, Profiles of Leading Players Abbott, Sysmex, Siemens Healthcare, ACON Laboratories, ARKRAY, Shenzhen Mindray Bio-Medical Electronics and More
The "Urine Cell Analyzer Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering....
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary
Sysmex's (TYO:6869) unit, Sysmex Shanghai, plans to inject capital to and become a shareholder of IVD Medical Holding's (HKG:1931) subsidiary, Vastec Medical Equipment (Shanghai), as part of a coopera
Comments
$SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS(SSMXY.US$@Alvinnnnnnn89is this under your radar? Did you buy?
1
1
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Alvinnnnnnn89 : cant buy on moomoo